These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29630024)

  • 1. An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.
    Batra P; Rafie S; Zhang Z; Singh AV; Bird CE; Sridhar A; Sullivan JG
    Obstet Gynecol; 2018 May; 131(5):850-855. PubMed ID: 29630024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
    Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
    J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators and barriers to implementing pharmacist-prescribed hormonal contraception in California independent pharmacies.
    Gomez AM; McCullough C; Fadda R; Ganguly B; Gustafson E; Severson N; Tomlitz J
    Women Health; 2020 Mar; 60(3):249-259. PubMed ID: 31264530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accessibility of Pharmacist-Prescribed Contraceptives in Utah.
    Magnusson BM; Christensen SR; Tanner AB; Eyring JB; Pilling EB; Sloan-Aagard CD
    Obstet Gynecol; 2021 Dec; 138(6):871-877. PubMed ID: 34735383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of pharmacist prescription of contraception in rural areas of Oregon and New Mexico.
    Rodriguez MI; Garg B; Williams SM; Souphanavong J; Schrote K; Darney BG
    Contraception; 2020 Mar; 101(3):210-212. PubMed ID: 31862410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
    Anderson L; Hartung DM; Middleton L; Rodriguez MI
    Obstet Gynecol; 2019 Jun; 133(6):1231-1237. PubMed ID: 31135739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The acceptability of contraception task-sharing among pharmacists in Canada--the ACT-Pharm study.
    Norman WV; Soon JA; Panagiotoglou D; Albert A; Zed PJ
    Contraception; 2015 Jul; 92(1):55-61. PubMed ID: 25818593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability of Pharmacist-Prescribed Contraception in Hawai'i.
    Collins-Doijode H; Oehlers J; Tyson J; Rodriguez MI; Kaneshiro B
    Hawaii J Health Soc Welf; 2022 Aug; 81(8):218-222. PubMed ID: 35923386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies.
    Lu S; Rafie S; Hamper J; Strauss R; Kroon L
    Contraception; 2019 Apr; 99(4):239-243. PubMed ID: 30562478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing pharmacist and clinician perspectives on pharmacist-prescribed hormonal contraceptives.
    Whalen A; Bratberg J; Cohen L; Orr K; Lemay V
    J Am Pharm Assoc (2003); 2024; 64(1):314-320.e3. PubMed ID: 37967721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879.
    Walsh S; Irwin AN; Anderson L; Zehrung C
    J Am Pharm Assoc (2003); 2019; 59(4S):S112-S116. PubMed ID: 31010785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient experiences with pharmacist prescribed hormonal contraception in California independent and chain pharmacies.
    Rafie S; Wollum A; Grindlay K
    J Am Pharm Assoc (2003); 2022; 62(1):378-386. PubMed ID: 34996577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community perspectives on pharmacist-prescribed hormonal contraception in rural California.
    Gomez AM; Rafie S; Garner-Ford E; Arcara J; Arteaga S; Britter M; De La Cruz M; Gleaton SK; Gomez-Vidal C; Luna B; Ortiz C; Rivera MC; Schuman L; Watanabe M; Logan R
    Contraception; 2022 Oct; 114():10-17. PubMed ID: 35671841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies.
    Chen L; Lim J; Jeong A; Apollonio DE
    J Am Pharm Assoc (2003); 2020; 60(6):963-968.e2. PubMed ID: 32800456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon.
    Gibbs SE; Harvey SM
    Contraception; 2020 Oct; 102(4):262-266. PubMed ID: 32652093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for and experience in obtaining pharmacist prescribed contraception.
    Rodriguez MI; Edelman AB; Skye M; Darney BG
    Contraception; 2020 Oct; 102(4):259-261. PubMed ID: 32502494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' comfort level and knowledge about prescribing hormonal contraception in a supermarket chain pharmacy.
    Lio I; Remines J; Nadpara PA; Goode JKR
    J Am Pharm Assoc (2003); 2018; 58(4S):S89-S93. PubMed ID: 30006191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of a pharmacist-led hormonal contraceptive prescribing service in a campus community pharmacy in Indiana, United States.
    Ahmad ZM; Noel NL; Rudd TM; Nadelson CS; Ott MA; Wilkinson TA; Meredith AH
    Contraception; 2022 Sep; 113():113-118. PubMed ID: 35577148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expectations of future provision of pharmacist-prescribed hormonal contraception in California.
    Gomez AM; McCullough C; Hoff C
    Am J Obstet Gynecol; 2018 Jun; 218(6):627-628. PubMed ID: 29474845
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacists' experience with prescribing hormonal contraception in Oregon.
    Rodriguez MI; Biel FM; Swartz JJ; Anderson L; Edelman AB
    J Am Pharm Assoc (2003); 2018; 58(6):608-613. PubMed ID: 30190201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.